Blood Glucose Monitoring Test Systems for Prescription Point-of-Care Use: Guidance for Industry and Food and Drug Administration Staff
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
September 29, 2020
January 26, 2021
4ea2f26d-acc7-4d7c-8b2e-18e0d211f522
Related Documents
Premarket Notification (510(k)) Submissions for Electrosurgical Devices for General Surgery: Guidance for Industry and Food and Drug Administration Staff
Guidance DocumentMarch 9, 2020Center for Devices and Radiological Health
Display Devices for Diagnostic Radiology: Guidance for Industry and Food and Drug Administration Staff
Guidance DocumentSeptember 28, 2022Center for Devices and Radiological Health
Self-Monitoring Blood Glucose Test Systems for Over-the-Counter Use: Guidance for Industry and Food and Drug Administration Staff
Guidance DocumentSeptember 29, 2020Center for Devices and Radiological Health
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox